Original article| Volume 42, 102132, July 2020

The possible beneficial effects of higher vitamin B6 intake from diet on cognitive function of patients with neuromyelitis optica spectrum disorder


      • NMOSD patients may encounter cognitive impairment.
      • It seems that vitamin B6 intake is associated with cognitive function.
      • Dietary B6 showed positive correlation with cognitive function in NMOSD patients.



      Given some evidence on the effects of vitamin B6 on cognitive function and the high prevalence of cognitive impairment in patients with Neuromyelitis Optica Spectrum Disorder (NMOSD), we conducted the present study to evaluate the correlation between dietary vitamin B6 intake and cognitive function among NMOSD patients.


      A cross-sectional study was designed on 24 definite NMOSD patients in Sina hospital, Tehran, Iran. A validated 168-item food frequency questionnaire was used to obtain the participants’ routine dietary habits. For the cognitive function assessment, Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) battery was administered. Vitamin B6 intake per day was calculated, and the correlation between vitamin B6 and the results of MACFIMS subtests was examined.


      The results revealed a positive correlation between dietary vitamin B6 intake and cognitive function in all subtests of MACFIMS. This direct correlation was significant in case of verbal and learning memory according to CVLT-II subtest (p-value:0.02; r:0.45) as well as speed of information processing and working memory according to SDMT subtest (p-value:0.04; r:0.43). The results from linear regression analysis adjusted for carbohydrate intake and disease duration indicated a significant ascending trend for the score of CVLT-II, SDMT, CVLT-II-delayed recall, and Brief Visuospatial Memory Test-Revised (BVMT-R) subtests through the quartiles of vitamin B6 intakes.


      Our finding indicated a positive correlation between higher dietary intake of vitamin B6 and cognitive function of NMOSD patients. Based on high prevalence of cognitive malfunction in NMOSD patients, these results are promising.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Multiple Sclerosis and Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Eskandarieh S.
        • Nedjat S.
        • Abdollahpour I.
        • Azimi A.R.
        • Moghadasi A.N.
        • Asgari N.
        • et al.
        Environmental risk factors in neuromyelitis optica spectrum disorder: a case-control study.
        Acta Neurol. Belg. 2018; 118: 277-287
        • Meng H.
        • Xu J.
        • Pan C.
        • Cheng J.
        • Hu Y.
        • Hong Y.
        • et al.
        Cognitive dysfunction in adult patients with neuromyelitis optica: a systematic review and meta-analysis.
        J. Neurol. 2017; 264: 1549-1558
        • Moore P.
        • Methley A.
        • Pollard C.
        • Mutch K.
        • Hamid S.
        • Elsone L.
        • et al.
        Cognitive and psychiatric comorbidities in neuromyelitis optica.
        J. Neurol. Sci. 2016; 360: 4-9
        • Eskandarieh S.
        • Nedjat S.
        • Azimi A.R.
        • Moghadasi A.N.
        • Sahraian M.A
        Neuromyelitis optica spectrum disorders in Iran.
        Mult. Scler. Relat. Disord. 2017; 18: 209-212
        • Rezaeimanesh N.
        • Jahromi S.R.
        • Moghadasi A.N.
        • Rafiee P.
        • Ghorbani Z.
        • Moghadam N.B.
        • et al.
        Dietary total antioxidant capacity and neuromyelitis optica spectrum disorder susceptibility.
        Nutr. Food Sci. 2019;
        • Rezaeimanesh N.
        • Jahromi S.
        • Ghorbani Z.
        • Moghadam N.
        • Hekmatdoost A.
        • Moghadasi A.
        • et al.
        Low carbohydrate diet score and neuromyelitis optica spectrum disorder.
        Mult. Scler. Relat. Disord. 2018; 26: 245
      1. The possible protective effects of whole grains and legumes consumption against neuromyelitis optica spectrum disorder odds.
        in: Rezaeimanesh N Jahromi SR Moghadasi AN Ghorbani Z Eskandarieh S Sahraian M MULTIPLE SCLEROSIS JOURNAL. Sage Publications Ltd 1 Olivers Yard, 55 City Road, London Ec1y 1SP, England, 2019
      2. Ditary animal protein sources in relation to risk of neuromyelitis optica spectrum disorder.
        in: Rezaeimanesh N Jahromi SR Ghorbani Z Hekmatdoost A Eskandarieh S Moghadasi AN Multiple Sclerosis Journal. Sage Publications Ltd 1 Olivers Yard, 55 City Road, London EC1Y 1SP, England, 2018
        • Rezaeimanesh N.
        • Jahromi S.
        • Ghorbani Z.
        • Moghadam N.
        • Hekmatdoost A.
        • Moghadasi A.
        • et al.
        Various types of dietary sugar and neuromyelitis optica spectrum disorder.
        Mult. Scler. Relat. Disord. 2018; 26: 244
        • An Y.
        • Feng L.
        • Zhang X.
        • Wang Y.
        • Wang Y.
        • Tao L.
        • et al.
        Dietary intakes and biomarker patterns of folate, vitamin B 6, and vitamin B 12 can be associated with cognitive impairment by hypermethylation of redox-related genes NUDT15 and TXNRD1.
        Clin. Epigenetics. 2019; 11: 139
        • Wingerchuk D.M.
        • Banwell B.
        • Bennett J.L.
        • Cabre P.
        • Carroll W.
        • Chitnis T.
        • et al.
        International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.
        Neurology. 2015; 85: 177-189
        • Mirmiran P.
        • Esfahani F.H.
        • Mehrabi Y.
        • Hedayati M.
        • Azizi F
        Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study.
        Public Health Nutr. 2010; 13: 654-662
        • Eshaghi A.
        • Riyahi-Alam S.
        • Roostaei T.
        • Haeri G.
        • Aghsaei A.
        • Aidi M.R.
        • et al.
        Validity and reliability of a persian translation of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).
        Clin. Neuropsychol. 2012; 26: 975-984
        • Gronwall D
        Paced auditory serial-addition task: a measure of recovery from concussion.
        Percept. Mot. Skills. 1977; 44: 367-373
        • Smith A
        Symbol digit modalities test: western Psychological Services Los Angeles.
        in: Spreen O Strauss E A compendium of neuropsychological tests. 2nd ed. 1998 (New. 1982)
      3. Delis D.C., Kaplan E., Kramer J.H. Delis-Kaplan Executive function system: examiners manual: psychological Corporation; 2001.

        • Benton A.L.
        • Sivan A.B.
        • deS Hamsher K.
        • Varney N.R.
        • Spreen O
        Contributions to Neuropsychological assessment: A clinical manual:.
        Oxford University Press, USA1994
      4. Benedict R.H. Brief visuospatial memory test-revised: professional manual: PAR; 1997.

        • Palacios N.
        • Scott T.
        • Sahasrabudhe N.
        • Gao X.
        • Tucker K.L
        Lower plasma vitamin B-6 is associated with 2-year cognitive decline in the Boston Puerto Rican health study.
        J. Nutr. 2019; 149: 635-641
        • Dror Y.
        • Stern F.
        • Nemesh L.
        • Hart J.
        • Grinblat J
        Estimation of vitamin needs—riboflavin, vitamin B6 and ascorbic acid-according to blood parameters and functional-cognitive and emotional indices in a selected well-established group of elderly in a home for the aged in Israel.
        J. Am. Coll. Nutr. 1996; 15: 481-488
        • Barichello T.
        • Generoso J.S.
        • Simões L.R.
        • Ceretta R.A.
        • Dominguini D.
        • Ferrari P.
        • et al.
        Vitamin B6 prevents cognitive impairment in experimental pneumococcal meningitis.
        Exp. Biol. Med. 2014; 239: 1360-1365
        • Guilarte T.R
        Vitamin B6 and cognitive development: recent research findings from human and animal studies.
        Nutr. Rev. 1993; 51: 193-198
        • Wei I.-.L.
        • Huang Y.-.H.
        • Wang G.-.S
        Vitamin B6 deficiency decreases the glucose utilization in cognitive brain structures of rats.
        J. Nutr. Biochem. 1999; 10: 525-531
        • Kirksey A.
        • Morré D.M.
        • Wasynczuk A.Z
        Neuronal development in vitamin B6 deficiency.
        Ann. N. Y. Acad. Sci. 1990; 585: 202-218
        • Groziak S.M.
        • Kirksey A.
        Effects of maternal restriction in vitamin B-6 on neocortex development in rats: neuron differentiation and synaptogenesis.
        J. Nutr. 1990; 120: 485-492
        • Messripour M.
        • Mesripour A.
        Effects of vitamin B6 on age associated changes of rat brain glutamate decarboxylase activity.
        Afr. J. Pharm. Pharmacol. 2011; 5: 454-456
        • Lewerenz J.
        • Maher P.
        Chronic glutamate toxicity in neurodegenerative diseases—what is the evidence?.
        Front. Neurosci. 2015; 9: 469
        • Schousboe A.
        • Scafidi S.
        • Bak L.K.
        • Waagepetersen H.S.
        • McKenna M.C
        Glutamate metabolism in the brain focusing on astrocytes.
        Glutamate and ATP At the Interface of Metabolism and Signaling in the Brain. Springer, 2014: 13-30
        • Malarkey E.B.
        • Parpura V.
        Mechanisms of glutamate release from astrocytes.
        Neurochem. Int. 2008; 52: 142-154
        • Mahmoud S.
        • Gharagozloo M.
        • Simard C.
        • Gris D
        Astrocytes maintain glutamate homeostasis in the CNS by controlling the balance between glutamate uptake and release.
        Cells. 2019; 8: 184
        • Da Silva A.P.B.
        • de Souza D.G.
        • Souza D.O.
        • Machado D.C.
        • Sato D.K
        Role of glutamatergic excitotoxicity in neuromyelitis optica spectrum disorders.
        Front. Cell Neurosci. 2019; 13: 142
        • Naser Moghadasi A.
        Environmental and genetic risk factors in the development of neuromyelitis optica.
        Expert Rev. Ophthalmol. 2020; : 1-9